Stay updated on Biomarker-Directed Combo for Advanced Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Biomarker-Directed Combo for Advanced Lung Cancer Clinical Trial page.

Latest updates to the Biomarker-Directed Combo for Advanced Lung Cancer Clinical Trial page
- Check3 days agoChange DetectedRecruitment status is updated to indicate the study is no longer enrolling, and results have been posted. The page adds or updates navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and clarifies the Pembrolizumab-based intervention arms, including removal of outdated entries.SummaryDifference5%

- Check11 days agoChange DetectedThe page's revision label updated to v3.5.5, replacing the prior v3.5.4 to reflect a newer version of the page metadata.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedResults Submitted is now shown, replacing the previous No Results Posted, and the page revision has been updated to v3.5.4, removing the earlier v3.5.3 reference.SummaryDifference0.1%

- Check54 days agoChange DetectedClinicalTrials.gov page revision identifier updated from **v3.5.2** to **v3.5.3**, reflecting a site/system version change rather than a change to the underlying trial information.SummaryDifference0.0%

- Check61 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check90 days agoChange DetectedThe Italy site name is updated from Napoli to Naples (80131), and the page revision now shows v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Biomarker-Directed Combo for Advanced Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Biomarker-Directed Combo for Advanced Lung Cancer Clinical Trial page.